Nieuwe literatuur

Een keer per jaar wordt per uitgangsvraag een literatuursearch verricht. Als deze search relevante informatie oplevert dan wordt de betreffende studie onder de tab ‘Nieuwe literatuur’ geplaatst. Daarnaast  worden vooruitlopend op deze jaarlijkse search incidenteel studies gevonden die eveneens van invloed kunnen zijn op de actualisatie van de richtlijn. Ook deze studies worden onder de tab ‘Nieuwe literatuur’ geplaatst. De werkgroep bespreekt alle nieuwe literatuur en vervolgens wordt besloten welke literatuur verwerkt wordt in de richtlijn en welke publicaties daarnaast in aanmerking komen voor verwerking in een evidence tabel. Op deze pagina kunt u zien of er nieuwe literatuur beschikbaar is.

Search januari 2018

Bromley, R. L., Calderbank, R., Cheyne, C. P., Rooney, C., Trayner, P., Clayton-Smith, J., . . . Baker, G. A. (2016). Cognition in school-age children exposed to levetiracetam, topiramate, or sodium valproate. Neurology, 87(18), 1943-1953. doi: 10.1212/wnl.0000000000003157. 

Diav-Citrin, O., Shechtman, S., Zvi, N., Finkel-Pekarsky, V., & Ornoy, A. (2017). Is it safe to use lamotrigine during pregnancy? A prospective comparative observational study. Birth Defects Res, 109(15), 1196-1203. doi: 10.1002/bdr2.1058. 

Hernandez-Diaz, S., McElrath, T. F., Pennell, P. B., Hauser, W. A., Yerby, M., & Holmes, L. B. (2017). Fetal growth and premature delivery in pregnant women on antiepileptic drugs. Ann Neurol, 82(3), 457-465. doi: 10.1002/ana.25031. 

Pariente, G., Leibson, T., Shulman, T., Adams-Webber, T., Barzilay, E., & Nulman, I. (2017). Pregnancy Outcomes Following In Utero Exposure to Lamotrigine: A Systematic Review and Meta-Analysis. CNS Drugs, 31(6), 439-450. doi: http://dx.doi.org/10.1007/s40263-017-0433-0.  Erratum in: https://www.ncbi.nlm.nih.gov/pubmed/28512694

Patorno, E., Bateman, B. T., Huybrechts, K. F., MacDonald, S. C., Cohen, J. M., Desai, R. J., . . . Hernandez, D. S. (2017). Pregabalin use early in pregnancy and the risk of major congenital malformations. Neurology, 88(21), 2020-2025. doi: http://dx.doi.org/10.1212/WNL.0000000000003959. 

Thomas, S. V., Jose, M., Divakaran, S., & Sankara Sarma, P. (2017). Malformation risk of antiepileptic drug exposure during pregnancy in women with epilepsy: Results from a pregnancy registry in South India. Epilepsia, 58(2), 274-281. doi: 10.1111/epi.13632. 

Vajda, F. J., O'Brien, T. J., Graham, J. E., Hitchcock, A. A., Lander, C. M., & Eadie, M. J. (2017). Antiepileptic drugs, foetal malformations and spontaneous abortions. Acta Neurol Scand, 135(3), 360-365. doi: 10.1111/ane.12672. 

Veroniki, A. A., Cogo, E., Rios, P., Straus, S. E., Finkelstein, Y., Kealey, R., . . . Tricco, A. C. (2017). Comparative safety of anti-epileptic drugs during pregnancy: a systematic review and network meta-analysis of congenital malformations and prenatal outcomes. BMC Med, 15(1), 95. doi: 10.1186/s12916-017-0845-1. 

Videman, M., Stjerna, S., Roivainen, R., Nybo, T., Vanhatalo, S., Gaily, E., & Leppanen, J. M. (2016). Evidence for spared attention to faces in 7-month-old infants after prenatal exposure to antiepileptic drugs. Epilepsy Behav, 64(Pt A), 62-68. doi: 10.1016/j.yebeh.2016.09.023. 

Weston, J., Bromley, R., Jackson, C. F., Adab, N., Clayton-Smith, J., Greenhalgh, J., . . . Marson, A. G. (2016). Monotherapy treatment of epilepsy in pregnancy: congenital malformation outcomes in the child. Cochrane Database Syst Rev, 11, Cd010224. doi: 10.1002/14651858.CD010224.pub2. 

Search januari 2019

Andrade, C.(2018). Adverse pregnancy outcomes associated with gestational exposure to antiepileptic drugs. Journal of Clinical Psychiatry, 79 (4) (no pagination)(18f12467). DOI: 10.4088/JCP.18f12467. 

Andrade, C.(2018). Major Congenital Malformations Associated With Exposure to Antiepileptic Drugs During Pregnancy. J Clin Psychiatry, 79(4). DOI: 10.4088/JCP.18f12449. 

Barton, S., et al.(2018). Memory dysfunction in school-aged children exposed prenatally to antiepileptic drugs. Neuropsychology, 32(7), 784-796. DOI: 10.1037/neu0000465.

Cohen-Israel, M., et al.(2018). Short- and long-term complications of in utero exposure to lamotrigine. Br J Clin Pharmacol, 84(1), 189-194. DOI: 10.1111/bcp.13437. 

Keni, R.R., et al.(2018). Teratogenicity of antiepileptic dual therapy: Dose-dependent, drug-specific, or both? Neurology, 90(9), e790-e796. DOI: 10.1212/wnl.0000000000005031. 

Koc, G., et al.(2018). Fetal safety of levetiracetam use during pregnancy. Acta Neurol Belg, 118(3), 503-508. DOI: 10.1007/s13760-018-0996-7. 

Reimers, A., et al.(2018). Zonisamide serum concentrations during pregnancy. Epilepsy Research, 144, 25-29. DOI: 10.1016/j.eplepsyres.2018.05.002. 

Thangaratinam, S., et al.(2018). Monitoring strategies for seizure control in pregnancy: A randomised controlled trial nested in a cohort study. BJOG: An International Journal of Obstetrics and Gynaecology, 125 (Supplement 1), 108-109. DOI: 10.1111/1471-0528.15132. Embase: 621569774.

Tomson, T., et al.(2018). Comparative risk of major congenital malformations with eight different antiepileptic drugs: a prospective cohort study of the EURAP registry. Lancet Neurol, 17(6), 530-538. DOI: 10.1016/s1474-4422(18)30107-8. 

Vajda, F.J.E., et al.(2018). Anti-epileptic drug exposure and risk of foetal death in utero. Acta Neurol Scand, 137(1), 20-23. DOI: 10.1111/ane.12816. 

 

Andrade, C.(2018). Adverse pregnancy outcomes associated with gestational exposure to antiepileptic drugs. Journal of Clinical Psychiatry, 79 (4) (no pagination)(18f12467). DOI: 10.4088/JCP.18f12467. https://www.ncbi.nlm.nih.gov/pubmed/30085439.

 

Andrade, C.(2018). Major Congenital Malformations Associated With Exposure to Antiepileptic Drugs During Pregnancy. J Clin Psychiatry, 79(4). DOI: 10.4088/JCP.18f12449. https://www.ncbi.nlm.nih.gov/pubmed/30153402.

 

Barton, S., et al.(2018). Memory dysfunction in school-aged children exposed prenatally to antiepileptic drugs. Neuropsychology, 32(7), 784-796. DOI: 10.1037/neu0000465. https://www.ncbi.nlm.nih.gov/pubmed/29975072.

 

Reimers, A., et al.(2018). Zonisamide serum concentrations during pregnancy. Epilepsy Research, 144, 25-29. DOI: 10.1016/j.eplepsyres.2018.05.002. https://www.ncbi.nlm.nih.gov/pubmed/29751353. 

 

Koc, G., et al.(2018). Fetal safety of levetiracetam use during pregnancy. Acta Neurol Belg, 118(3), 503-508. DOI: 10.1007/s13760-018-0996-7. https://www.ncbi.nlm.nih.gov/pubmed/30056483.

Cohort studie, geen grote bewijskracht, ondersteunt wel al bekende gegevens. Hierbij ook weer de vraag of we dit wel moeten meenemen gezien grote hoeveelheid waarin hetzelfde. Toch meenemen en samenvatten of vanwege te lage bewijskracht maar laten???Dick, Cees, Evie??

 

Thangaratinam, S., et al.(2018). Monitoring strategies for seizure control in pregnancy: A randomised controlled trial nested in a cohort study. BJOG: An International Journal of Obstetrics and Gynaecology, 125 (Supplement 1), 108-109. DOI: 10.1111/1471-0528.15132. Embase: 621569774. https://obgyn.onlinelibrary.wiley.com/doi/10.1111/1471-0528.8_15132

 

Tomson, T., et al.(2018). Comparative risk of major congenital malformations with eight different antiepileptic drugs: a prospective cohort study of the EURAP registry. Lancet Neurol, 17(6), 530-538. DOI: 10.1016/s1474-4422(18)30107-8. https://www.ncbi.nlm.nih.gov/pubmed/29680205.

 

Vajda, F.J.E., et al.(2018). Anti-epileptic drug exposure and risk of foetal death in utero. Acta Neurol Scand, 137(1), 20-23. DOI: 10.1111/ane.12816. https://www.ncbi.nlm.nih.gov/pubmed/28857118.

 

Cohen-Israel, M., et al.(2018). Short- and long-term complications of in utero exposure to lamotrigine. Br J Clin Pharmacol, 84(1), 189-194. DOI: 10.1111/bcp.13437. https://www.ncbi.nlm.nih.gov/pubmed/29044597

 

Keni, R.R., et al.(2018). Teratogenicity of antiepileptic dual therapy: Dose-dependent, drug-specific, or both? Neurology, 90(9), e790-e796. DOI: 10.1212/wnl.0000000000005031. https://www.ncbi.nlm.nih.gov/pubmed/29429975.